ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $206,000 | +32.1% | 22,417 | +10.8% | 0.00% | – |
| Q4 2016 | $156,000 | -26.4% | 20,238 | +9.3% | 0.00% | -100.0% |
| Q3 2016 | $212,000 | +1.9% | 18,520 | +9.6% | 0.00% | 0.0% |
| Q2 2016 | $208,000 | +24.6% | 16,895 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $167,000 | -54.6% | 16,470 | +1.0% | 0.00% | 0.0% |
| Q4 2015 | $368,000 | +49.0% | 16,305 | +9.7% | 0.00% | 0.0% |
| Q3 2015 | $247,000 | -23.3% | 14,870 | +4.0% | 0.00% | 0.0% |
| Q2 2015 | $322,000 | +5.6% | 14,295 | +20.8% | 0.00% | 0.0% |
| Q1 2015 | $305,000 | +36.8% | 11,830 | +15.6% | 0.00% | 0.0% |
| Q4 2014 | $223,000 | -3.5% | 10,230 | +3.0% | 0.00% | 0.0% |
| Q2 2014 | $231,000 | – | 9,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |